No Data
No Data
Express News | Applied DNA Receives Approval for Tr8(Tm) Pharmacogenomic (Pgx) Testing Service From New York State Department of Health
Express News | New York State Department Of Health Approved Applied DNA For TR8 Pharmacogenomic Testing Service
Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service From New York State Department of Health
STONY BROOK, NY / ACCESSWIRE / June 13, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that the New York Stat
Applied DNA Sciences Is Maintained at Buy by HC Wainwright & Co.
Applied DNA Sciences Is Maintained at Buy by HC Wainwright & Co.
AMD To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Susquehanna
Applied DNA Sciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/10/2024 199.4% HC Wainwright & Co. $7 → $1.5 Maintains Buy 05/13/2024 1297.21% HC Wainwright & Co. $1.5
No Data